173341-02-1 Usage
Description
2-N-BOC-Aminomethylmorpholine, with the chemical formula C10H20N2O3, is a member of the morpholine chemical family. It features a morpholine ring and a tert-butoxycarbonyl (BOC) protecting group, which is commonly used in chemistry to prevent unwanted reactions. The presence of an amine group makes this compound valuable in pharmaceutical development and the synthesis of complex organic compounds. Due to its reactivity, it is typically stored under inert gas conditions.
Uses
Used in Pharmaceutical Development:
2-N-BOC-Aminomethylmorpholine is used as a reactant or raw material for the synthesis of various pharmaceutical compounds. Its amine group and BOC protecting group facilitate the creation of new drug molecules, contributing to the advancement of medicinal chemistry.
Used in Organic Synthesis:
In the field of organic chemistry, 2-N-BOC-Aminomethylmorpholine is employed as a building block for the synthesis of complex organic compounds. Its unique structure allows for the formation of diverse chemical entities, expanding the scope of organic synthesis.
Used in Industrial Processes:
2-N-BOC-Aminomethylmorpholine is utilized in various industrial applications, where its chemical properties are harnessed to produce a range of products. Its versatility and reactivity make it a valuable component in the manufacturing of specialty chemicals and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 173341-02-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,3,3,4 and 1 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 173341-02:
(8*1)+(7*7)+(6*3)+(5*3)+(4*4)+(3*1)+(2*0)+(1*2)=111
111 % 10 = 1
So 173341-02-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H20N2O3/c1-10(2,3)15-9(13)12-7-8-6-11-4-5-14-8/h8,11H,4-7H2,1-3H3,(H,12,13)
173341-02-1Relevant articles and documents
INDAZOLE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
-
Page/Page column 39, (2015/07/07)
The present invention relates to novel indazole compounds of the Formula (I), wherein, R1 is alkyl or cycloalkyl; (Formula II) including their stereoisomers and their pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-Hydroxytryptamine 4 (5-HT4) receptor agonists
ANTIBACTERIAL AGENTS
-
Page/Page column 56-57, (2010/10/19)
Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
NOVEL COMPOUNDS WITH ANTIBACTERIAL ACTIVITY
-
Page/Page column 89-90, (2010/02/06)
The invention relates to novel antibacterial compounds of formula (I).